Fulminant parvovirus B19 myocarditis in infants -report of three post-pandemic cases.

Fulminant parvovirus B19 myocarditis in infants -report of three post-pandemic cases.

Publication date: Feb 17, 2025

Lack of immune stimulation (“immune debt”) in the wake of the COVID-19 pandemic has led to a resurgence of many paediatric infectious diseases, recently including parvovirus B19 (PVB19). We observed three cases of fulminant PVB19 myocarditis in infants. All had experienced a short prodromal illness and succumbed to cardiogenic shock within 2-72 h after admission. The risk of fulminant myocarditis appears to be increased in infants. Further studies are needed to assess the incidence of fulminant myocarditis caused by PVB19, potentially linked to immune debt.

Concepts Keywords
Increased “immune debt”
Infants Fulminant
Myocarditis Myocarditis
Parvovirus Parvovirus B19 virus
Pvb19

Semantics

Type Source Name
disease MESH myocarditis
disease MESH COVID-19 pandemic
disease MESH infectious diseases
disease MESH cardiogenic shock

Original Article

(Visited 1 times, 1 visits today)